Prescription Drug User Fee Act Reauthorization (no number), provisions relating to approval of new drugs.  H.R. 4132 - Faster Access to Specialized Treatments Act, all sections; S. 2113 Transforming the Regulator Environment to Accelerate Access to Treatments, all sections. FDA appeal process for new drug applications.  Prescription Drug and User Fee Act Reauthorization (no number), provisions relating to approval of new drugs.
PHA - Pharmacy MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
DENNY MILLER ASSOCIATES
400 N Capitol St, Ste 363, Washington, DC, 20001, US
JUDSON GREIF JUDSON GREIF